The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes

This publication has 21 references indexed in Scilit:

• Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.
  Journal of Clinical Investigation, 1995
• The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children.
  Journal of Clinical Investigation, 1995
• Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
  Nature, 1992
• The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
  New England Journal of Medicine, 1992
• Plasminogen activator inhibitor in plasma is related to testosterone in men
  Metabolism, 1989
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985